Pharmaceutical involvement in phase II breast cancer clinical trials

被引：1
|
作者：
Schneider, A.
Zhang, T.
Kamal, A.
Patel, K.
Hamilton, E. P.
Peppercorn, J. M.
机构：
[1] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[2] Duke Univ, Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.6104
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6104
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Pharmaceutical involvement in breast cancer clinical trials.
    Peppercorn, JM
    Blood, E
    Winer, EP
    Partridge, AH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 542S - 542S
  • [2] Association between pharmaceutical involvement and outcomes in breast cancer clinical trials
    Peppercorn, Jeffrey
    Blood, Emily
    Winer, Eric
    Partridge, Ann
    CANCER, 2007, 109 (07) : 1239 - 1246
  • [3] Phase II clinical trials with rhizoxin in breast cancer and melanoma
    Hanauske, AR
    Catimel, G
    Aamdal, S
    Huinink, WT
    Paridaens, R
    Pavlidis, N
    Kaye, SB
    teVelde, A
    Wanders, J
    Verweij, J
    BRITISH JOURNAL OF CANCER, 1996, 73 (03) : 397 - 399
  • [4] Phase II and III clinical trials of toremifene for metastatic breast cancer
    Vogel, CL
    ONCOLOGY-NEW YORK, 1998, 12 (03): : 9 - 13
  • [5] The role of biologic therapy in phase II breast cancer clinical trials
    Patel, K.
    Kamal, A.
    Zhang, T.
    Schneider, A.
    Hamilton, E. P.
    Peppercorn, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Pharmacogenomic predictor discovery in phase II clinical trials for breast cancer
    Pusztai, Lajos
    Anderson, Keith
    Hess, Kenneth R.
    CLINICAL CANCER RESEARCH, 2007, 13 (20) : 6080 - 6086
  • [7] Statistical design in phase II clinical trials and its application in breast cancer
    Perrone, F
    Di Maio, M
    De Maio, E
    Maione, P
    Ottaiano, A
    Pensabene, M
    Di Lorenzo, G
    Lombardi, AV
    Signoriello, G
    Gallo, C
    LANCET ONCOLOGY, 2003, 4 (05): : 305 - 311
  • [8] Phase II Cancer Prevention Clinical Trials
    Szabo, Eva
    SEMINARS IN ONCOLOGY, 2010, 37 (04) : 359 - 366
  • [9] Methodology of phase II clinical trials in metastatic elderly breast cancer: a literature review
    B. Cabarrou
    L. Mourey
    F. Dalenc
    L. Balardy
    D. Kanoun
    H. Roché
    J. M. Boher
    M. E. Rougé-Bugat
    Thomas Filleron
    Breast Cancer Research and Treatment, 2017, 164 : 505 - 513
  • [10] Methodology of phase II clinical trials in metastatic elderly breast cancer: a literature review
    Cabarrou, B.
    Mourey, L.
    Dalenc, F.
    Balardy, L.
    Kanoun, D.
    Roche, H.
    Boher, J. M.
    Rouge-Bugat, M. E.
    Filleron, Thomas
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (03) : 505 - 513
12345